Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Lithium Does Not Slow Progression of ALS
Link ID 24081
Title Lithium Does Not Slow Progression of ALS
Url http://www.medscape.com/viewarticle/719770?src=rss
Description Lithium did not delay the progression of amyotrophic lateral sclerosis (ALS) in a randomized placebo-controlled trial, the investigators reported online April 6 in The Lancet Oncology. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Apr 7, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. CNS Effects of Beta-Blockers May Contribute to Benefits in Heart Failure
  The beneficial effects of beta-adrenoceptor blockade on the failing heart may derive from their effects in the central nervous system (CNS), according to a report in the March 28th issue of Circulation Research. Reuters Health Information
Category:   Articles > Pharmacists


2. Ezogabine: A New Drug for Seizure ControlEzogabine: A New Drug for Seizure Control
  Dr. Andrew Wilner discusses the FDAs approval of ezogabine for partial seizure control. What role will the drug play in clinical practice? br / iMedscape Neurology/i
Category:   Articles > Pharmacists


3. Fullerene Blocks Articular Cartilage Degeneration
  Water-soluble C60 fullerene prevents the degeneration of articular cartilage in a rabbit model of osteoarthritis (OA) through the downregulation of chondrocyte catabolic activity, according to Japanese researchers. Reuters Health Information
Category:   Articles > Pharmacists


4. Vascular Dementia
  Therapy for cognitive impairment caused by cerebrovascular disease is challenging -- the key may be in its prevention. U.S. Pharmacist
Category:   Articles > Pharmacists


5. Drugmakers See Pain From Reform, Price Pressures
  Four large U.S. and European drugmakers unveiled cautious 2011 forecasts, as higher costs from U.S. healthcare reform will further hurt an industry grappling with patent expirations and pressure to curb prices. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS